Skip to main content
Fig. 2 | Respiratory Research

Fig. 2

From: Effects of gastroesophageal reflux disease treatment with proton pump inhibitors on the risk of acute exacerbation and pneumonia in patients with COPD

Fig. 2

Risk of study outcomes in patients with prevalent chronic obstructive pulmonary disease. In population 1, the IRRs of moderate and severe exacerbation and pneumonia during the PPI treatment period were calculated, compared to that at the baseline. Population 2 comprised patients with an observation period of at least 90 days after PPI discontinuation, and the IRRs of moderate and severe exacerbation and pneumonia during the PPI treatment and post-treatment periods were calculated. AE acute exacerbation, IRR incidence rate ratio, CI confidence interval, PPI proton pump inhibitor

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us